Elena Vladimirovna Korotkova

Ms. Elena Vladimirovna Korotkova

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2026 in Journal of Biomedical Photonics & Engineering
Verified
Journal Article
Open access
PDF file
DKDmitrii Krasnov
Dmitrii Krasnov
ASAleksey Shmonin
Aleksey Shmonin
VMVolynsky A Maxim
Volynsky A Maxim
NMNikita Margaryants
Nikita Margaryants
AGAlexander Gusev
Alexander Gusev
EKElena Vladimirovna Korotkova
Elena Vladimirovna Korotkova
Computer-vision methods have been applied to automated behavior recognition in laboratory rodents. Namely, we explored the possibility of classifying certain behavior classes from still images; compared keypoint-based methods with approaches based on visual embeddings; studied the feasibility of transferring models between rats and mice; and evaluated the relevance of the number and the accuracy of the detected keypoints. We collected a dataset of a freely moving Wistar rat to train six pose-based classifiers with Long Short-Term Memory (LSTM) using six sets of keypoints produced by two detectors and four Convolutional Neural Network (CNN) classifiers using images and optical flow frames. The results demonstrated the highest mean average precision (mAP) of 65.7% for the CNN-based methods and 34.3% for the LSTM classifiers, the feasibility of recognizing visually distinct classes (rearing and body grooming) from still images, and the applicability of a keypoint detector trained on mice. The results of this study can be applied to the design of a computer vision system for automating long-term monitoring of laboratory rodent behavior

20 December 2024 in Russian Journal of Geriatric Medicine
Verified
Journal Article
Open access
PDF file
EKElena Vladimirovna Korotkova
Elena Vladimirovna Korotkova
AZA. V. Zavyalov
A. V. Zavyalov
AKA. Yu. Kovalenko
A. Yu. Kovalenko
Lipoprotein (а) is able to initiate mechanisms of inflammation and create an atherogenic and thrombophilic condition due to its structural features. It is important to acknowledge that there are currently no standardized protocols for the regular monitoring of lipoprotein (а) levels in clinical settings, despite its relevance in assessing cardiovascular risk among older patients. Even in the absence of abnormal lipid profiles, there may still be thickening of the arterial walls and the formation of atherosclerotic plaque. The extent of atherogenicity, or plaque development, is directly linked to plasma levels of lipoprotein (а), which have a genetic basis.This paper aims to review the role of lipoprotein (а) in low-grade inflammation and its pathogenic mechanisms in atherosclerosis, particularly in relation to elevated levels of this lipoprotein. The study will critically analyze the available literature on this topic to understand the potential role of lipoprotein (а) as a risk factor for atherosclerosis.

18 May 2026 in Diabetes mellitus
Verified
Journal Article
Closed access
MCM. E. Chernaya
M. E. Chernaya
YKY. S. Khalimov
Y. S. Khalimov
AVA. R. Volkova
A. R. Volkova
ALA. V. Lisker
A. V. Lisker
ANA. A. Nersesyan
A. A. Nersesyan
YOY. A. Obiedkova
Y. A. Obiedkova
BACKGROUND: The problem of achieving target glycemic control in patients with diabetes mellitus type 1 (T1DM) remains relevant. Currently, new, more technologically advanced methods of insulin therapy (IT) are being actively developed — one of them is the IT method of a closed loop (do-it-yourself closed loop system, DIY-CLS). This type of therapy is not registered in Russia, however, patients install these systems themselves, in connection with which it seems important to discuss the principle of DIY-CLS operation, the possibilities and prospects of their use. OBJECTIVE : To evaluate the glycemic control indicators, the frequency of acute complications of diabetes in patients with type 1 diabetes on different types of therapy. MATERIALS AND METHODS : We observed 98 patients who were divided into 3 groups: patients using MII (n=40), patients with CSII (n=40) and patients with DIY-CLS (n=18). All groups were comparable in age, sex and the duration of T1DM history. RESULTS: The majority of patients were women (73.47%), the average age was 33.3±2.4 years, the duration of diabetes was 17.1±2.2 years. It was found that in patients from the DIY-CLS group, compared with the MII and CSII groups, according to continuous glucose monitoring, the time in range was significantly higher, the mean glucose, standard deviation, time above range 10.1–13.9 mmol/l and time above range >13.9 mmol/l were significantly lower. The number of hypoglycemic states and hyperglycemic events leading to the development of ketosis was comparable. CONCLUSION: Glycemic control values were significantly better in patients using DIY-CLS. Patients in the DIY-CLS group more often achieved target time above range and coefficient of variation levels.